Enovix’s (ENVX) “Outperform” Rating Reiterated at William Blair

William Blair reiterated their outperform rating on shares of Enovix (NASDAQ:ENVXFree Report) in a report published on Thursday, RTT News reports.

Several other analysts have also weighed in on ENVX. Cantor Fitzgerald restated an overweight rating and issued a $30.00 price objective on shares of Enovix in a report on Thursday, April 25th. Canaccord Genuity Group reissued a buy rating and issued a $17.00 price objective on shares of Enovix in a research report on Wednesday, February 21st. JPMorgan Chase & Co. dropped their price target on shares of Enovix from $18.00 to $12.00 and set an overweight rating for the company in a research report on Friday, April 26th. Finally, B. Riley cut their price target on shares of Enovix from $18.00 to $16.00 and set a buy rating for the company in a report on Tuesday, April 30th. One equities research analyst has rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of Moderate Buy and an average target price of $25.29.

Read Our Latest Research Report on ENVX

Enovix Trading Up 6.5 %

Shares of ENVX stock traded up $0.62 during trading hours on Thursday, reaching $10.09. 11,963,656 shares of the company’s stock were exchanged, compared to its average volume of 5,634,649. The company has a debt-to-equity ratio of 0.65, a quick ratio of 5.15 and a current ratio of 5.30. The company’s 50 day moving average is $7.88 and its two-hundred day moving average is $10.01. Enovix has a 1 year low of $5.70 and a 1 year high of $23.90.

Enovix (NASDAQ:ENVXGet Free Report) last posted its quarterly earnings results on Tuesday, February 20th. The company reported ($0.35) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.34) by ($0.01). The firm had revenue of $7.38 million for the quarter, compared to analysts’ expectations of $3.37 million. Enovix had a negative net margin of 1,448.90% and a negative return on equity of 83.66%. Analysts anticipate that Enovix will post -1.13 earnings per share for the current year.

Insider Activity at Enovix

In related news, COO Ajay Marathe sold 4,954 shares of the company’s stock in a transaction that occurred on Sunday, April 14th. The stock was sold at an average price of $7.31, for a total value of $36,213.74. Following the sale, the chief operating officer now directly owns 978,913 shares in the company, valued at $7,155,854.03. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 17.30% of the stock is owned by company insiders.

Institutional Trading of Enovix

Several large investors have recently modified their holdings of the stock. Allspring Global Investments Holdings LLC purchased a new position in shares of Enovix during the third quarter valued at approximately $31,000. Beacon Capital Management LLC grew its stake in Enovix by 66.7% during the fourth quarter. Beacon Capital Management LLC now owns 2,500 shares of the company’s stock valued at $31,000 after acquiring an additional 1,000 shares in the last quarter. Carmel Capital Partners LLC bought a new stake in Enovix during the third quarter valued at $34,000. Able Wealth Management LLC bought a new position in shares of Enovix in the fourth quarter worth approximately $34,000. Finally, Quest Partners LLC purchased a new position in Enovix in the fourth quarter worth $49,000. Institutional investors and hedge funds own 50.92% of the company’s stock.

Enovix Company Profile

(Get Free Report)

Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.

Featured Stories

Analyst Recommendations for Enovix (NASDAQ:ENVX)

Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.